# Biomedical Technology Program

> **NIH NIH P30** · UNIVERSITY OF CALIFORNIA AT DAVIS · 2022 · $108,694

## Abstract

BIOMEDICAL TECHNOLOGY PROGRAM (BTP)
PROJECT SUMMARY/ABSTRACT
The central theme of the Biomedical Technology Program (BTP) is to establish novel technologies and
computational methods to prevent and/or reduce the cancer burden in the UC Davis Comprehensive Cancer
Center (UCDCCC) catchment area and beyond. The Program brings together engineers, physical scientists,
and applied physicists who collaborate with key clinical investigators in the School of Medicine (SOM) and
School of Veterinary Medicine (SVM) with the goal of translating new or adapted technologies to improve
cancer detection, diagnosis, and therapy. BTP has four Specific Aims that encompass the broad technological
expertise found within the Program. Aim 1 is to develop and validate radiological diagnostic and therapeutic
technologies. Aim 2 is to develop and validate optical spectroscopic and imaging technologies (Biophotonics).
Aim 3 is to develop molecular and cellular technologies for translational and clinical applications. Aim 4 is to
develop and validate computational methods and Artificial Intelligence (AI) techniques. Laura Marcu, PhD
(biomedical engineering) and Ramsey Badawi, PhD (radiological sciences) are co-leaders for BTP. The
Program’s research portfolio encompasses a wide range of technologies and computational methods, from
transformative developments related to PET and CT (including the development of the world’s first total-body
PET scanner), and establishing fluorescence lifetime imaging as a means for intra-operative tissue
characterization, to developing novel theranostic agents for imaging and therapy, and developing robust neural
networks and other Artificial Intelligence (AI) techniques to improve cancer imaging. BTP has 21 full members
from three schools/colleges and seven departments at UC Davis. BTP’s total cancer relevant funding is $9.6M
annual direct cost, including $8.9M in peer-reviewed and $4.6M in NCI funding. The total number of
publications is 313 of which 22% are intra-programmatic, 42% inter-programmatic, 46% multi-institutional, and
15% published in high impact journals. As a strong Program with several technologies entering clinical
implementation or evaluation, the UCDCCC has deployed measures to ensure technology development and
clinical translation continue. This includes institutional support to maintain robust transdisciplinary fora and
provide discretionary funding support to the BTP, providing its leadership the ability to support pilot projects
that will continue the Program’s transformative impact.

## Key facts

- **NIH application ID:** 10492555
- **Project number:** 5P30CA093373-20
- **Recipient organization:** UNIVERSITY OF CALIFORNIA AT DAVIS
- **Principal Investigator:** RAMSEY D. BADAWI
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $108,694
- **Award type:** 5
- **Project period:** 2002-07-01 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10492555

## Citation

> US National Institutes of Health, RePORTER application 10492555, Biomedical Technology Program (5P30CA093373-20). Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/grant/nih/10492555. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*